Abstract
Wilson disease (WD) is an autosomal recessive disorder of copper metabolism with an incidence of between 1:35 000 and 1:100 000 (1). The disorder manifests itself as chronic liver disease and/or later on, with neurological symptoms, due to gradual accumulation of copper (2,3). The gene responsible for Wilson disease has recently been mapped to chromosome 13 and cloned (4,5); it encodes a P-type ATPase involved in copper transport across membranes. To date more than 25 mutations have been identified in the ATP7B gene responsible for WD and among them two very common mutations have been reported. The first, His1070G ln, is a C to A transversion in exon 14 of the gene, with an allele frequency of 28% in the Northern European population. The other, Gly1267Lys, is a G to A transversion in exon 18 of the gene, with an allele frequency of 10% in the Northern European population (6). We investigated the prevalance of these 2 mutations in 40 French WD patients from 22 unrelated French families using fluorescence-based Single-Strand Conformational Polymorphisms (F-SSCP) analysis with subsequent direct sequencing of the abnormally shifted exons.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
D.M. Danks, in Metabolic Basis of Inherited Disease, A.L. Beaudet, W.S. Sly, D. Valle, eds., McGraw-Hill, New York, pp. 1411–1431 (1989).
R.H.J. Houwen, J. Van Hattum, T.U. Hoogenraad, Neth. J. Med. 43, 26–37 (1993).
G.J. Brewer, V. Yuzbasiyan-Gurkan, Medicine 71, 139–164 (1992).
P.C. Bull, G.R. Thomas, J.M. Rommens, J.R. Forbes, D.W. Cox, Nature Genet. 5, 327–337 (1993).
R.E. Tanzi, K. Petrukhin, I. Chernov, et al., Nature Genet. 5, 344–350 (1993).
G.R. Thomas, J.R. Forbes, E.A. Roberts, J.M. Walshe, D.W. Cox, Nature Genet. 9, 210-217.
G.R. Thomas, P.C. Bull, E.A. Roberts, J.M. Walshe, D.W. Cox, Am. J. Hum. Genet. 54, 71–78 (1994).
B. Aral, M. Coudé, J. Aupetit, I. Ceballos-Picot, P. Kamoun, B. Chadefaux-Vekemans, Meths. Mol Cell Biol. 5,237–241 (1995).
A. Figus et al., Am. J. Hum. Genet. 57, 1318–1324 (1995).
D.H. MacLennan, D.M. Clarke, T.W. Loo, I.S. Skerjanc, Acta Physiol. Scand. 146, 141–150 (1992).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Liu, G., Aral, B., Ceballos-Picot, I., Franvel, C., Lecoz, P., Chappuis, P. (1996). F-SSCP Screening for Two Common Mutations HIS1070GLN and GLY1267LYS in French Wilson Patients, and Report of Two Novel Mutations. In: Nève, J., Chappuis, P., Lamand, M. (eds) Therapeutic Uses of Trace Elements. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0167-5_76
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0167-5_76
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0169-9
Online ISBN: 978-1-4899-0167-5
eBook Packages: Springer Book Archive